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Abstract
 
Objective
 
To identify pathoaetiological neuroimmune mechanisms in
patients with atopic dermatitis (AD) and chronic stress, focusing at nerve
density, sensory neuropeptides, and the serotonergic system.
 
Methods
 
Eleven patients with AD with histories of stress worsening were
included. Biopsies from involved and non-involved skin were processed for
immunohistochemistry. Salivary cortisol test was done as a marker for chronic stress.
 
Results
 
There were more acanthosis and fewer nerve ﬁbres in epidermis and
papillary dermis of involved compared with non-involved skin. Whereas there
was no signiﬁcant change in the number of substance P and calcitonin gene-
related peptide–positive nerve ﬁbres between the involved and non-involved
skin, there was an increase in the epidermal fraction of 5-hydroxtrytamine 1A
(5-HT1A) receptor and serotonin transporter protein (SERT) immunoreactivity
in the involved skin. The number of 5-HT2AR, CD3-positive cells, and SERT-
positive cells, most of them being CD3 positive, was increased in involved skin.
There was an increase in mast cells in the involved skin, and these cells were
often located close to the basement membrane. There was a strong tendency to
a correlation between 5-HT2AR positive cells in the papillary dermis of involved
skin and low cortisol ratios, being an indicator of chronic stress.
 
Conclusion
 
A changed innervation and modulation of the serotonergic
system are indicated in chronic atopic eczema also during chronic stress.
 
Introduction
 
Atopic dermatitis (AD) is a common chronic skin disease,
which affects about 2% to 3% of the adult population.
 
1
 
 It
produces an extremely itchy skin. A marked increase in
the prevalence of AD in urbanized societies has occurred
during the past decades.
 
2
 
The aetiology of AD is unknown but is probably multi-
factorial, with interactions between several genetic and
environmental factors.
 
3
 
 Stress aggravates the symptoms.
 
4
 
The skin controls and transmits contacts with the
external world. It is an integral component of the
immune, nervous, and endocrine systems, and there are
numerous lines of crosstalk between these systems estab-
lished intracutaneously.
 
5
 
 The skin contains an extensive
neural network represented by unmyelinated sensory ﬁbres
and receptors for neuropeptides and neurotransmitters
identical to those expressed in the central neuroendocrine
system.
 
6
 
The free nerve endings of the sensory nerves, C-ﬁbres,
are widely distributed in the epidermis, and most of them
reach the stratum granulosum. Activation of sensory
unmyelinated neurones evokes the release of neuropeptides,
such as substance P.
The neuropeptides substance P and calcitonin gene-
related peptide (CGRP) have speciﬁc biological effects and
are a link between the neuroendocrine and immune
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axis.
 
7,8
 
 Functional dysregulation of neuropeptides may be
involved in the pathogenesis of AD.
 
9,10
 
The substance P–related receptor (R), the neurokinin-1
(NK-1) R, is expressed by human keratinocytes, endothelial
cells, ﬁbroblasts, and mast cells. Activation of this receptor
stimulates proliferation of keratinocytes, ﬁbroblasts, and
endothelial cells.
 
8,11
 
C-ﬁbres in the skin interact with mast cells. An increased
number of mast cell nerve contacts are observed in dermal
skin of AD compared with those in healthy skin.
 
12
 
Serotonin [5-hydroxtrytamine (5-HT)] is an amine that
acts as a neurotransmitter in a wide variety of sites in the
central and peripheral nervous system.
 
13
 
 It is involved in
numerous body functions. Functional dysregulation may
lead to sleep disorders, anxiety, depression, and aggressivity.
Serotonin is also of importance for basic cell functions such
as proliferation, differentiation, maturation, and migration.
Serotonin is present in serotonergic neurones in the central
nervous system, and in the periphery, it is released from
platelets and mast cells (in rodents) after tissue injury.
Pathways for the biosynthesis and biodegradation of
serotonin have been characterized in human and rodent
skin and in their major cellular populations.
 
13
 
 Serotonin
in the skin causes pro-oedema, vasodilatory, proinﬂam-
matory, and pruritogenic effects via its receptors.
 
14
 
Serotonin generally exerts its effects through seven
families of receptors.
 
15
 
 Of these subtypes, the 5HT1A and
5HT2A receptors have been suggested to have opposing
functions in a variety of cellular and behavioural proc-
esses.
 
16
 
 The serotonin transporter protein (SERT) regulates
5-HT concentrations in the synaptic cleft via recycling
released serotonin, thus terminating the action of 5-HT,
and is a target for serotonin reuptake inhibitors.
Psychological stress can provoke many cutaneous
dermatoses associated with abnormal epidermal barrier
function, such as AD.
 
17
 
 Stress involves different neurome-
diators, such as sensory neuropeptides, including the sub-
stance P-NK-1 receptor system,
 
11
 
 and the serotonergic system,
in, for example, raphe.
 
18
 
 There is a colocalization of serotonin
and sensory neuropeptides in the nervous system.
 
19
 
In the present study, we investigated patients with AD,
with histories of chronic stress, taking biopsies for immu-
nohistochemistry, studying nerve density, expression of
sensory neuropeptides and serotonin and its receptors, as
well as SERT. We investigated levels of salivary cortisol as
an indicator of chronic stress.
 
20
 
Patients and methods
 
Patients
 
Eleven patients (three male and eight female) with a
mean age of 34.0 (range, 27–41), who had active AD,
moderate to severe (as deﬁned by the criteria by Haniﬁn
and Rajka),
 
21
 
 were referred to the Neurocutaneous
reception at our department by other dermatologists.
Each had a history of eczema that worsened during stress.
Ethical permission was obtained from the local ethical
committee.
 
Salivary cortisol tests
 
Salivary cortisol samples were obtained from all patients.
The salivary samples were collected in plastic vials at 08:00 h
on three consecutive days. At 10:00 h p.m. on the last
day, 0.25  mg dexamethasone was administered orally,
followed by a new cortisol test on the following morning.
The samples were stored at –20 
 
°
 
C until analysis. The
cortisol concentrations were determined using a radio-
immunoassay kit (Spectria Cortisol, Orion Diagnostica,
Espoo, Finland) after centrifugation of the samples. The
ratio of the mean of the previous three values to the last
cortisol value was determined, a low ratio being an
indicator of chronic stress.
 
20
 
Skin biopsies
 
Four-millimetre biopsies were taken from the lesional
skin on the thighs who had marked dryness, grouped
papulovesicles, conﬂuent read oedematous areas, and
non-lesional skin on the gluteal region on the same
patient, after an injection of lidocaine. These sites had not
been treated with topical steroids for at least 14 days. The
biopsies were ﬁxed in Lanas ﬁx (10% formalin and 0.4%
picric acid) at 4 
 
°
 
C for 2 h. They were then rinsed in cold
phosphate buffer with 10% sucrose (4 
 
°
 
C) for at least
48 h, snap frozen, and stored at –70 
 
°
 
C until being further
processed.
 
Immunohistochemistry
 
Fourteen-micrometre cryostat sections were made on a
Dittes cryostate. The slides were incubated overnight
(4 
 
°
 
C) in a humid chamber with primary antibodies
(Table 1).
The sections were rinsed in PBS and incubated with a
biotinylated goat anti-rabbit secondary antibody, in case
of polyclonal antibodies, or, in case of the monoclonal
antibodies, with a biotinylated horse anti-mouse secondary
antibody, for 40  min (Table  1). The primary antibodies
were visualized by incubating the sections with the
fluorochrome Cy2.
As a control, the primary antibodies (PGP 9.5) were
omitted, or the antisera (substance P, CGRP, and 5-HT1A)
R were pre-adsorbed with the pure neuropeptides (Bachem)
at 10
 
–5
 
 mol/L overnight, or with the 5-HT1AR antigenic 
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peptide (synthesized by Ross-Petersen AS, Horsholm,
Denmark and used at a concentration of 0.1  mg/mL),
respectively, at 4 
 
°
 
C, when no immunoreactivity was
obtained. In case of the monoclonal antibodies, control
with mouse IgG of the same isotype (DakoCytomation),
and in the same dilution as this antibody, was used. In
addition, these control experiments resulted in omitted
immunoreactivity.
In the double-staining experiments, the same principle
method was used, however, with different ﬂuorochromes.
Double staining was done for 5-HT2AR or SERT and FITC-
conjugated CD3. In these experiments, streptavidin-
conjugated Texas red was used to detect the primary
antibodies. In the case of SERT, we also used a double
staining using a polyclonal antibody to tryptase (from Prof
Ilkka Harvima, Department of Dermatology, University of
Tampere, Finland).
The sections were then rinsed in PBS, mounted in
gelatine/glycerol, and examined with epiﬂuorescence using
a Nikon epiﬂuorescence microscope (Eclipse E800,
Yokohama, Japan). The Cy2 and FITC-ﬂuorescent struc-
tures were visualized with a ﬁlter cube with excitation at
465 to 495 nm, whereas Texas red ﬂuorescent elements
were seen with a ﬁlter cube with excitation at 540 to
580 nm.
Photographs were taken using a video camera system
(Nikon digital camera DXM 1200) attached to a ﬂuorescent
microscope and connected to a PC computer. The slides
were coded before an examination was done by one
observer (HR) who was not aware of the results of stress
nor location of the biopsies.
Epidermal degree of thickness, acanthosis, was evaluated
using a semiquantitative scale. The acanthosis was graded
as normal (low), moderate, or high, giving a score of 1, 2,
or 3, respectively.
An epidermal staining was evaluated by giving fraction/
ratio of the total epidermis.
Labelled nerves and cells were counted in the whole
epidermis and papillary dermis. In each biopsy, counts
were made of two sections and another two sections
70 
 
μ
 
m from the ﬁrst one.
 
Statistical analysis
 
The Wilcoxon test was used to analyse dependent data
and statistical comparisons to test differences between
involved and non-involved skin. The Spearman rank
correlation coefﬁcient was used to test dependence
between the cortisol ratios and number of PGP 9.5-,
substance P-, and CGRP-positive nerve ﬁbres and number
of 5HT1AR, 5-HT2AR, SERT-positive cells and mast cells,
respectively, in the involved and non-involved skin.
The level of signiﬁcance was set at 
 
P
 
 < 0.05.
 
Results
 
Cortisol ratio
 
Cortisol values were obtained from eight patients (mean,
2.9 ± 2.5; Tables 2 and 3). There was a strong tendency
(
 
P = 
 
0.08) to a correlation between lower serum cortisol
ratios and number of 5-HT2AR-positive cells in the
papillary dermis of involved skin.
 
Acanthosis
 
All subjects exhibited a higher degree (
 
P < 
 
0.001) of
acanthosis in involved [2.4 ± 0.5 (SD)] compared with
non-involved (1.3  ±  0.4) skin. The involved skin also
showed signs for a light to moderate inﬂammation and
hyperkeratosis.
 
PGP 9.5
 
There was a decrease (
 
P < 
 
0.001) in the number of
PGP 9.5–positive ﬁbres (ﬁg. 1a,b, shown for epidermis),
in involved skin (22.9 ± 10.8) and 75.5 ± 21.2, ﬁbres
per section in the epidermis and dermis, respectively,
Anti-PGP 9.5, polyclonal, rabbit (1:10 000), UltraClone, Isle of Wight, UK
Anti-5HT1AR 170IV, polyclonal, rabbit (1:5000)37
Anti-5HT2AR, monoclonal, mouse (1:500), PharMingen, San Diego, CA, USA38
Anti-substance P, polyclonal, rabbit (1:10 000), Bachem, St. Helens, UK
Anti-CGRP, polyclonal, rabbit (1:10 000), Bachem
Anti-CD3, monoclonal, mouse, FITC-conjugated (1:20), PharMingen
SERT, ST51-1, monoclonal, mouse (1:20 000), MabTechnologies, Stone Mountain, GA, USA
Anti-tryptase, monoclonal, mouse (1:5000), Chemicon, Temecula, CA, USA
Biotinylated anti-rabbit, goat (1:200), Vector, Burlingame, CA, USA
Biotinylated anti-mouse, horse (1:200), Vector
Anti-rabbit, swine, FITC-conjugated (1:40), DakoCytomation, Glostrup, Denmark
Streptavidin-conjugated Cy2 (1:2000), Amersham, Buckinghamshire, UK
Streptavidin-conjugated Texas red (1:2000), Vector
Table 1 Antibody description 
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Table 2
 
Non-involved skin
 
Patients Cortisol Acanthosis
PGP 9.5 ﬁbres Substance P ﬁbres CGRP 5HT1AR 5HT2AR SERT
Mast
cells Epidermis
Papillary 
dermis Epidermis
Papillary 
dermis Epidermis
Papillary 
dermis
Epidermal 
fraction
Papillary 
dermis cells
Papillary 
dermis cells
Epidermal 
fraction
Papillary 
dermis cells
 
1 0.6 1 82 117 1 9 2 3 0.2 93 2 0.3 59 113
2 2.3 1 93 113 1 9 1 8 0.2 57 2 0.3 39 52
3 2.4 1 45 113 1 19 0 10 0.3 62 0 0.3 69 62
4 2.4 2 52 130 1 4 0 0 0.3 88 0 0.3 30 142
5 4.1 1 66 109 1 16 2 15 0.3 76 0 0.3 122 169
6 5.1 1 105 165 1 26 1 13 0.3 75 2 0.3 81 107
7 8.1 1 60 102 2 4 1 3 0.3 76 1 0.5 20 320
8 – 1 64 105 1 10 1 9 0.3 84 3 0.3 36 81
9 – 2 97 175 2 14 0 12 1 82 0 0.3 71 90
10 0.5 2 91 130 1 4 1 3 0.3 60 1 0.3 122 43
11 – 1 56 121 1 3 0 1 0.3 57 0 0.5 23 133
 
Table 3 
 
Involved skin
 
Patient Cortisol Acanthosis
PGP 9.5 ﬁbers Substance P ﬁbers CGRP 5HT1AR 5HT2AR SERT
Mast 
cells Epidermis
Pap. 
derm Epidermis
Pap. 
derm Epidermis
Pap. 
derm
Epidermal 
fraction
Pap. derm 
cells
Pap.derm 
cells
Epidermal 
fraction
Pap.derm. 
cells
 
1 0.6 3 9 62 0 1 1 1 0.7 118 51 0.5 141 498
2 0.3 3 37 118 17 30 11 28 0.3 51 5 1.0 156 86
3 2.4 2.5 14 93 5 19 1 7 0.5 27 55 0.3 95 112
4 2.4 2 16 53 1 7 0 4 0.2 74 625 0.1 75 176
5 4.1 2 20 63 0 6 1 11 0.5 93 12 0.5 120 200
6 5.1 2 32 82 4 22 0 11 0.5 61 2 0.5 108 140
7 8.1 2 15 35 1 4 0 1 0.5 41 1 0.5 127 628
8 – 1.5 18 82 1 9 1 4 0.5 69 3 0.5 111 204
9 – 3 41 80 8 28 3 5 0.5 27 5 0.5 111 116
10 0.5 2 37 89 5 16 0 1 1 82 238 0.3 45 66
11 – 3 16 76 1 6 0 1 0.5 69 10 0.5 56 216 
Lonne-Rahm 
 
et al.
 
Neuroimmune mechanisms in atopic dermatitis
 
© 2008 The Authors
 
15
 
JEADV
 
 2008, 
 
22
 
, 11–18 Journal compilation © 2008 European Academy of Dermatology and Venereology
 
compared with the non-involved skin (73.8 ± 19.7 and
125.3 ± 22.1; ﬁg. 2a,b).
 
Mast cells
 
There was an increase (
 
P < 
 
0.01) in mast cells, round to
dendritic in the involved skin, 222.0  ±  169.7 cells per
section, compared with non-involved skin (119.3 ± 73.6;
ﬁg.  2c). The mast cells in the involved skin showed a
tendency to attach to the epidermis (ﬁg. 1c).
 
Sensory neuropeptides
 
In the epidermis, 3.8 ± 5.0 ﬁbres per section were positive
for substance P (data not shown) in the involved skin,
compared with 1.1 ± 0.4 in the non-involved skin. In the
papillary dermis, there was no signiﬁcant distinction between
involved (13.3 ± 9.7) and non-involved (10.2 ± 0.6) skin.
There were also a few ﬁbres positive for CGRP in the
epidermis (data not shown) but no signiﬁcant difference
in ﬁbre density between involved (1.6 ± 3.0) and non-
involved (0.8 ± 0.7) skin, as was the case for the papillary
dermis (involved skin, 6.6 ± 7.6 and non-involved skin,
6.9 ± 5.1).
In one of the patients with a low cortisol ratio, there
was a large number of substance P
 
-
 
 and CGRP-positive
ﬁbres in both the epidermis and dermis.
 
Serotonin receptor 1A
 
The staining of the epidermis for 5-HT1AR (ﬁg. 1d) was
more extensive (
 
P = 
 
0.05) in the involved compared with
the non-involved skin. The outer half part, 0.5 ± 0.2 of
total epidermal layer, was positively stained compared
with one third, 0.3 ± 0.2, in the non-involved epidermis.
5-HT1AR–positive melanocyte-like cells with varying dendri-
city were seen on the basal membrane; their dendrites
seemed longer in the involved skin.
There was no difference between the number of 5-
HT1AR–positive cells in the papillary dermis in the involved
(72.9 ± 31.2 cells per section) and non-involved (74.1 ±
12.1) skin. Double staining showed that the majority
of the 5-HT1AR-positive cells in papillary dermis were
positive for tryptase (not shown).
 
Serotonin receptor 2A
 
The apical epidermis was stained up to half of its thickness
in 5 of 11 patients in the involved skin and in 6 of 11
patients in the non-involved skin (ﬁg. 1e). There was a
staining of the basal membrane, which often extended to
the basal cell layer in the involved skin in 6 of 11 patients
and in the non-involved skin in 5 of 11 patients.
5-HT2AR-positive cells were found in involved skin
both in the epidermal and the dermal layers. An increased
(
 
P < 
 
0.001) number of 5-HT2AR-positive cells was found
in the papillary dermis of the involved skin (95.4 ± 184.5
cells per section) compared with non-involved skin
(0.7 ± 0.8; ﬁg. 2d). Double staining showed that these 5-
HT2AR-positive cells were positive for CD3 (ﬁg. 3a,b).
 
SERT
 
There was an increased (
 
P < 
 
0.05) immunoreactivity in
the upper part of the epidermis (ﬁg. 1f
 
)
 
, a higher fraction
of the epidermis (0.5 ± 0.2) being affected in the involved
compared to the non-involved (0.4  ±  0.1) skin. An
increased (
 
P < 
 
0.01) number of SERT-positive cells were
 
 
 
 
   
   
 
 
   
ﬁg. 1 Epidermal PGP 9.5-positive nerve ﬁbres in (a) non-involved (b) and
involved AD skin. Tryptase-positive mast cells in proximity to the basal
membrane (c) and 5-HT1AR expression in involved skin (d). Note the apical
epidermal expression of 5-HT1AR, the dendritic melanocytes (arrow), as
well as the mononuclear cells (arrows) in the dermis. 5-HT2AR–positive api-
cal epidermis, basal membrane, and cells (arrow) that also intrude into the
epidermis of involved skin (e). SERT expression in the epidermis and dermal
cells (arrow) of involved skin (f). Magniﬁcation, ×200. 
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found in the dermis of the involved (104.1  ±  32.6)
compared with non-involved (61.1 ± 34.6) skin (ﬁg. 2e).
Some patients also had SERT-positive cells in the epidermis
of the involved skin. The majority of the SERT-positive
cells were CD3 positive (ﬁg. 3c,d), whereas a few were
tryptase positive (data not shown).
 
Discussion
 
In the present investigation, we report a decreased
innervation in the involved compared to non-involved
skin in AD patients. We found an increased epidermal
fractional immunoreactivity for 5-HT1AR and SERT
and an increased number of dermal 5-HT2AR and
SERT-positive cells, also the number of mast cells being
increased in the involved skin.
It has earlier been reported that the density of cutaneous
nerves is higher in atopic skin than in the skin of healthy
controls.
 
22,23
 
 The quality of nerve ﬁbres are also changed
in AD patients, the nerve endings being thin and running
straight through the epidermis.
 
24
 
The free nerve endings in lesional skin of AD might be
in an active state of excitation that have effect on
keratinocytes.
 
25
 
In a previous study,
 
26
 
 there was a decreased number of
PGP 9.5–positive ﬁbres and NGF receptor in the epidermis
in patients with prurigo nodularis. Maybe the loss of ﬁbres
is due to mechanical damage, which might lead to collateral
sprouting of other nerve ﬁbres or regeneration of the
damaged nerve ﬁbres.
There was an increase in the ratio of 5-HT1AR and SERT
fractions of the immunoreactive epidermis in involved
compared to non-involved skin. This is interesting since
there is a relation between 5-HT1AR and SERT, the function
of SERT and inﬂuence on the 5-HT concentration being
associated with a modulation of 5-HT1A autoreceptors.
 
27
 
A modulation of the skin barrier has been reported to be
due to psychological stress.
 
17
 
The stress response in the skin seems to be served by
locally expressed neuroendocrine activities.
 
28
 
 The skin is a
powerful steroidogenic tissue and involved in the production
of steroids.
 
29
ﬁg. 2 Graphs showing number of epidermal (a)
and dermal (b) PGP 9.5-positive ﬁbres, mast cells
(c), 5-HT2AR- (d), and SERT- (e) positive cells in
involved and non-involved skin, respectively. 
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The creation of a skin barrier is linked to a decreased
production of lamellar bodies, which in turn is attributed
to a diminished de novo synthesis of epidermal lipids,
including cholesterol.
 
17
 
 Cholesterol is an essential com-
ponent of eucaryotic membranes. It is of special interest
that the function of the 5-HT1AR is dependent on
cholesterol (see ref. 
 
30
 
). In this respect, it may be men-
tioned that cholesterol can also be metabolized to steroid
hormones in the skin.
 
31
 
 In addition, the 5-HT1A and 5-
HT2A receptor functions have been reported to be
dependent on steroids.
 
32
 
Regarding the intrusion of 5-HT2AR-positive cells
into the epidermis, this might be due to effect on inter-
stitial collagenases, being mediated by the 5-HT2AR
(see ref. 
 
33
 
). An antagonist to the 5-HT2A receptor has
been shown to decrease the expression of matrix
metalloproteinase.
 
34
 
There was a strong tendency (
 
P = 
 
0.08) to a correlation
between lower serum cortisol ratios, being an indicator of
chronic stress, and number of 5-HT2AR-positive cells
in the papillary dermis of the eczematous skin. The
5-HT2AR in the brain cortex has been reported to be
up-regulated during chronic stress due to maternal
deprivation.
 
35
 
The mast cells in the present investigation could be seen
to be increased in the involved compared to non-involved
skin and as well to attach to the basement membrane.
Mast cells are known to be able to activate matrix
metalloproteinases via the production of tryptase.
 
36
 
Tryptase itself and the activated matrix proteinases can
degrade various components of the pericellular/extracel-
lular matrix.
It is of value for the AD patients to reduce stress in
addition to the use of topical or oral treatment for the
inﬂammation. In addition, pharmacological treatment
targeting the serotonergic receptors and SERT might be a
possible treatment strategy.
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